Septic Encephalopathy

  • G. B. Young

Abstract

Of in-patients with positive blood cultures, we found that over 70% had some evidence of brain dysfunction [1]. Forty-six percent of these were in the intensive care unit (ICU), with the rest on the wards. The encephalopathy associated with systemic infections is a diffuse disturbance in cerebral function. Septic encephalopathy is a diagnosis of exclusion: there should be no clinical or laboratory evidence of direct central nervous system (CNS) infection (e.g., meningitis, macroscopic intra-cranial abscess or empyema), head trauma, fat embolism, adverse reactions to medications, sedative or paralyzing drug effects.

Keywords

Dopamine Glutathione Serotonin Neuropathy Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Young GB, Bolton CF, Austin TW (1990) The encephalopathy associated with septic illness. Clin Invest Med 13: 297–304PubMedGoogle Scholar
  2. 2.
    Jackson AC, Gilbert JJ, Young GB, Bolton CF (1985) The encephalopathy of sepsis. Can J Neurol Sci 12: 303–307PubMedGoogle Scholar
  3. 3.
    du Moulin GC, Paterson D, Hedley-White J, Broitman SA (1985) E. coli peritonitis and bacteremia cause increased blood-brain barrier permeability. Brain Res 340: 261–268Google Scholar
  4. 4.
    Spain DA, Wilson MA, Bar-Natan MF, Garrison RN (1994) Nitric oxide synthetase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 36: 720–725PubMedCrossRefGoogle Scholar
  5. 5.
    Papadopoulos MC, Davies DC, Moss RF, et al (2000) Pathophysiology of septic encephalopathy: a review. Crit Care Med 28: 3019–3024PubMedCrossRefGoogle Scholar
  6. 6.
    Zhao ML, Liu JS, He D, et al (1998) Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from the adult human brain. Brain Res 813: 402–405PubMedCrossRefGoogle Scholar
  7. 7.
    Freund HR, Muggia-Sullam M, Peiser J, Melamed E (1985) Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat. J Surg Res 38: 267–271PubMedCrossRefGoogle Scholar
  8. 8.
    Schafer DF, Jones EA (1982) Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet I: 18–20Google Scholar
  9. 9.
    Millen KD, Szauter KM, Kaminsky-Russ (1990) “Endogenous” benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336: 81–83Google Scholar
  10. 10.
    Moroni F, Lombardi G, Carlà V, et al (1986) Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J Neurochem 47: 1667–1671PubMedCrossRefGoogle Scholar
  11. 11.
    Bolton CF, Young GB, Zochodne DW (1993) The neurological complications of sepsis. Ann Neurol 33: 94–100PubMedCrossRefGoogle Scholar
  12. 12.
    Zochodne DW, Bolton CF, Wells GA, et al (1987) Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain 110: 819–842PubMedCrossRefGoogle Scholar
  13. 13.
    Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA (1992) The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 9: 145–152PubMedCrossRefGoogle Scholar
  14. 14.
    Sprung CL, Cerra FB, Freund HR (1991) Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med 19: 753–757PubMedCrossRefGoogle Scholar
  15. 15.
    Pine RW, Wertz MJ, Lennard ES (1983) Determinants of organ malfunction or death in patients with intra-abdominal sepsis. Arch Surg 118: 242–249PubMedCrossRefGoogle Scholar
  16. 16.
    Freund HR, Ryan JA, Fischer JE (1978) Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg 188: 423–430PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • G. B. Young

There are no affiliations available

Personalised recommendations